Neuroone Medical Technologies is trading 5.4% up at $1.71, with today’s gain appearing catalyst-unclear based on the provided live price context.
- No new company-specific announcement or filing dated September 8, 2026 was identified.
- The latest material developments were successful StereoCED large-animal procedures reported August 27 and an August 13 quarterly update citing 16% revenue growth but manufacturing-related shipment constraints.
- Broader healthcare sentiment is weak.